Defibrotide for the treatment of hepatic veno‐occlusive disease/sinusoidal obstruction syndrome following nontransplant‐associated chemotherapy: Final results from a post hoc analysis of data from an expanded‐access program

Pediatric Blood &Cancer, EarlyView.


https://ift.tt/2JdQk4q